What does T.DIFFUSION do?

T.DIFFUSION is a healthcare practice in Nivelles. Public Limited, started on 19 December 1977, 1 establishment.

What is the address of T.DIFFUSION?

The registered office of T.DIFFUSION is located at Avenue Thomas Edison 32, 1402 Nivelles.

Is T.DIFFUSION still active?

Yes. According to the CBE (29 October 2026) T.DIFFUSION is active, legal situation “Normale toestand”, started on 19 December 1977.

Is T.DIFFUSION registered on Peppol?

Yes, T.DIFFUSION is registered on the Peppol network with ID 0208:0418157102.

What is the enterprise number of T.DIFFUSION?

The enterprise number of T.DIFFUSION is BE0418157102.

When was T.DIFFUSION founded?

T.DIFFUSION was founded on 19 December 1977.

Who are the directors of T.DIFFUSION?

According to the 2025 annual accounts, the directors of T.DIFFUSION are: FOXFIN BV SRL, MEDECA BV SRL, ERUDITE BV SRL.

Is T.DIFFUSION a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 December 1977; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did T.DIFFUSION make in 2025?

T.DIFFUSION posted a profit after taxes of € 141,001 in financial year 2025.

What is the revenue of T.DIFFUSION?

As a small company, T.DIFFUSION is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,021,102.

T.DIFFUSION (Public Limited) - Nivelles - BE0418157102

Dossier T.DIFFUSION, printed on 29 October 2026 from databakkes.be/en/0418157102/t-diffusion. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 5 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

T.DIFFUSION from Nivelles, company number BE0418157102, closed financial year 2025 with a result of € 141,001 after tax. For that financial year T.DIFFUSION recorded a gross margin of € 1 million and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 289,496 to € 141,001. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Growing

€ 1.3 million

▲ 50% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 141,001

▼ 51% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 48,758

▼ 47% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 508,421.

Debts at end 2025

Bank debt ≈ 13 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 10.1 million

▼ 7% vs 2024

€ 746,667 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.

Owed to suppliers

€ 304,212

▲ € 302,532 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 21,499

▼ 53% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 1,111,831 Gross margin 2022: € 1,111,831 First fiscal year in the series	€ 1,209,847 Gross margin 2023: € 1,209,847 ▲ 9% vs 2022 (€ 1,111,831) Favourable step	€ 1,250,416 Gross margin 2024: € 1,250,416 ▲ 3% vs 2023 (€ 1,209,847) Favourable step	€ 1,021,102 Gross margin 2025: € 1,021,102 ▼ 18% vs 2024 (€ 1,250,416) Unfavourable step	▼ 18%
Profit after taxes	€ 332 Profit after taxes 2022: € 332 First fiscal year in the series	€ 332,797 Profit after taxes 2023: € 332,797 ▲ € 332,465 vs 2022 (€ 332) Favourable step	€ 289,496 Profit after taxes 2024: € 289,496 ▼ 13% vs 2023 (€ 332,797) Unfavourable step	€ 141,001 Profit after taxes 2025: € 141,001 ▼ 51% vs 2024 (€ 289,496) Unfavourable step	▼ 51%
Equity	€ 438,533 Equity 2022: € 438,533 First fiscal year in the series	€ 658,819 Equity 2023: € 658,819 ▲ 50% vs 2022 (€ 438,533) Favourable step	€ 835,804 Equity 2024: € 835,804 ▲ 27% vs 2023 (€ 658,819) Favourable step	€ 1,250,925 Equity 2025: € 1,250,925 ▲ 50% vs 2024 (€ 835,804) Favourable step	▲ 50%
Total debts	€ 5,644,946 Total debts 2022: € 5,644,946 First fiscal year in the series	€ 4,961,204 Total debts 2023: € 4,961,204 ▼ 12% vs 2022 (€ 5,644,946) Favourable step	€ 11,044,065 Total debts 2024: € 11,044,065 ▲ 123% vs 2023 (€ 4,961,204) Unfavourable step	€ 10,445,148 Total debts 2025: € 10,445,148 ▼ 5% vs 2024 (€ 11,044,065) Favourable step	▼ 5%
Cash	€ 340,343 Cash 2022: € 340,343 First fiscal year in the series	€ 37,940 Cash 2023: € 37,940 ▼ 89% vs 2022 (€ 340,343) Unfavourable step	€ 92,079 Cash 2024: € 92,079 ▲ 143% vs 2023 (€ 37,940) Favourable step	€ 48,758 Cash 2025: € 48,758 ▼ 47% vs 2024 (€ 92,079) Unfavourable step	▼ 47%
Land & buildings	€ 5,655,958 Land & buildings 2022: € 5,655,958 First fiscal year in the series	€ 4,788,822 Land & buildings 2023: € 4,788,822 ▼ 15% vs 2022 (€ 5,655,958) Unchanged	€ 3,917,186 Land & buildings 2024: € 3,917,186 ▼ 18% vs 2023 (€ 4,788,822) Unchanged	€ 3,069,089 Land & buildings 2025: € 3,069,089 ▼ 22% vs 2024 (€ 3,917,186) Unchanged	▼ 22%
Retained profit	€ -254,873 Retained profit 2022: € -254,873 First fiscal year in the series	€ 77,924 Retained profit 2023: € 77,924 ▲ € 332,797 vs 2022 (€ -254,873) Favourable step	€ 367,420 Retained profit 2024: € 367,420 ▲ € 289,496 vs 2023 (€ 77,924) Favourable step	€ 508,421 Retained profit 2025: € 508,421 ▲ 38% vs 2024 (€ 367,420) Favourable step	▲ 38%
Bank debt	€ 5,371,748 Bank debt 2022: € 5,371,748 First fiscal year in the series	€ 4,934,860 Bank debt 2023: € 4,934,860 ▼ 8% vs 2022 (€ 5,371,748) Favourable step	€ 10,852,023 Bank debt 2024: € 10,852,023 ▲ 120% vs 2023 (€ 4,934,860) Unfavourable step	€ 10,080,001 Bank debt 2025: € 10,080,001 ▼ 7% vs 2024 (€ 10,852,023) Favourable step	▼ 7%
Balance sheet total	€ 6,083,479 Balance sheet total 2022: € 6,083,479 First fiscal year in the series	€ 5,620,023 Balance sheet total 2023: € 5,620,023 ▼ 8% vs 2022 (€ 6,083,479) Unchanged	€ 11,879,869 Balance sheet total 2024: € 11,879,869 ▲ 111% vs 2023 (€ 5,620,023) Unchanged	€ 11,696,073 Balance sheet total 2025: € 11,696,073 ▼ 2% vs 2024 (€ 11,879,869) Unchanged	▼ 2%

Key figures of T.DIFFUSION, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to T.DIFFUSION?

What happened at T.DIFFUSION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 FOXFIN BV SRL stepped down as director. NBB
2030 MEDECA BV SRL stepped down as director. NBB
2030 ERUDITE BV SRL stepped down as director. NBB
Jun 30, 2026 New annual accounts for financial year 2025: profit of € 141,001 (▼ 51% vs 2024). Source: NBB ↗
2024 FOXFIN BV SRL became a director. NBB
2024 MEDECA BV SRL became a director. NBB
2024 ERUDITE BV SRL became a director. NBB
Jan 1, 1978 New establishment in Nivelles. KBO

In short

From € 332 profit in 2022 to € 141,001 profit in 2025.

Paid € 169,452 in corporate taxes since 2022.

Best year ever: 2023, with € 332,797 profit.

Original PDFs at the National Bank ↗

Management

Trenker HoldCo 100%

ROBINWOOD 98.6%

The stake of Trenker HoldCo, ROBINWOOD comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

T.DIFFUSION

The shares are held by Trenker HoldCo (100%) and ROBINWOOD (98.6%).

Directors

According to the 2025 annual accounts

FOXFIN BV SRL

Director · represented by Barbara De Saedeleer

Also active at: RECTICEL, S.A. Laboratoires Pharmaceutiques Trenker, UNICUM TRADE BOTANICALS, BEAULIEU INTERNATIONAL GROUP, ROBINWOOD, B.I.G COORDINATION CENTER, ORSI ACADEMY, KOLMONT HOLDING +2 more

since 2024 · until 2030

MEDECA BV SRL

Director · represented by Charles Declerck

Also active at: S.A. Laboratoires Pharmaceutiques Trenker, ROBINWOOD, NUTRIPHYT, TRENKER NUTRITION, Erudite.Health, Trenker HoldCo, Erudite Corporate

since 2024 · until 2030

ERUDITE BV SRL

Director · represented by Louis Declerck

Also active at: S.A. Laboratoires Pharmaceutiques Trenker, ROBINWOOD, NUTRIPHYT, TRENKER NUTRITION, Erudite.Health, Trenker HoldCo, Erudite Corporate

since 2024 · until 2030

Shareholders

Trenker HoldCo

100%

ROBINWOOD

98.6%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Thomas Edison 32

1402 Nivelles

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

N.V. Farmaceutische Laboratoria Trenker same network

€ 29 million revenue · 2025

Unité TRENKER

TRENKER NUTRITION same network

€ -320 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0418.157.102

VAT number

BE 0418.157.102

Registered office

Avenue Thomas Edison 32, 1402 Nivelles

Names & denominations

T.DIFFUSION

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

19 December 1977

Peppol

Active · Active since 2 Jun 2026

Activities · NACE

Activiteiten op het gebied van voeding

Paramedische activiteiten, exclusief kinesitherapeuten

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

T.DIFFUSION

Warning lights

Financials

What happened to T.DIFFUSION?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions